论文信息 - A phase I study of temsirolimus as novel therapeutic drug for patients with unresectable hepatocellular carcinoma (HCC). - 字舞流文

A phase I study of temsirolimus as novel therapeutic drug for patients with unresectable hepatocellular carcinoma (HCC).

W. Yeo | E. Hui | B. Ma | F. Mo | A. Chan | S. Chan | K. To | J. Koh | Leung Li | Simon Yu | W. Ho | J. Hui | H. Loong | Cm Chu